Stefanie Hagenow

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 2

Top Topics

Inflammatory Response

Molecular Docking

Lipopolysaccharide Induced

Top Venues

Angewandte Chemie (International ed. in English)

Drug design, development and therapy

Heinrich-Heine-Universität Düsseldorf

Heinrich-Heine-Universitat Düsseldorf (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Heinrich-Heine-Universität Düsseldorf Jan 1o 2019 - Jul 12o 2019

Germany

Researcher Postdoc :: Institute of Pharmaceutical and Medicinal Chemistry

Education History

Heinrich-Heine-Universitat Düsseldorf

Germany

MSC :: Institute of Toxicology

Publications

Jens Hagenow, Stefanie Hagenow, Kathrin Grau, Mohammad Khanfar, Lena Hefke, Ewgenij Proschak, Holger Stark
Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs. Drug design, development and therapy 14 (2020)
Óscar M Bautista-Aguilera, Stefanie Hagenow, Alejandra Palomino-Antolin, Víctor Farré-Alins, Lhassane Ismaili, Pierre-Louis Joffrin, M Luisa Jimeno, Ondrej Soukup, Jana Janočková, Lena Kalinowsky, Ewgenij Proschak, Isabel Iriepa, Ignacio Moraleda, Johannes S Schwed, Alejandro Romero Martínez, Francisco López-Muñoz, Mourad Chioua, Javier Egea, Rona R Ramsay, José Marco-Contelles, Holger Stark
Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3 R Antagonism for Neurodegenerative Diseases. Angewandte Chemie (International ed. in English) 56 (41) (2017)